The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease episode artwork

EPISODE · May 30, 2025 · 46 MIN

The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease

from Keeping Current CME

Targeting the cardiovascular (CV)-kidney-metabolic (CKM) axis may improve outcomes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) by addressing interconnected metabolic, kidney, and CV risks.   Credit available for this activity expires: 5/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002559?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published May 30, 2025

Embed this episode

NOW PLAYING

The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease

0:00 46:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 46 minutes long.

When was this Keeping Current CME episode published?

This episode was published on May 30, 2025.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!